Six months after naming Todd Young as its chief financial officer, Acadia Healthcare (Nasdaq: ACHC) announced he will depart. David Duckworth will return to the helm as its interim CFO beginning May 1.
Young, who joined Acadia from his CFO role at Elanco Animal Health, will return to a private equity-backed animal health company after he departs Acadia on April 30. He is still expected to lead the company’s upcoming first-quarter earnings call that is slated for that same day.
Duckworth was Acadia’s acting CFO from April 2011 through July 2023. Heather Dixon, who Young succeeded, was named as Duckworth’s replacement after his departure.
Duckworth will serve in an interim capacity until the company selects a permanent CFO. In January, Acadia announced another former executive, Debbie Osteen, would step in as interim CEO after Chris Hunter’s departure. She previously led the company as its CEO from December 2018 until March 2022.
“We are pleased to welcome David back as interim chief financial officer,” Osteen said in a press release. “He brings a deep understanding of Acadia, our operations, and our industry, along with strong relationships with the company’s leadership team and board. David’s experience will be invaluable as we continue executing our strategic priorities to position Acadia for near- and long-term success and value creation.”
The search for a permanent CEO is ongoing.
Acadia has faced multiple legal and financial headwinds over the last year, but still reported a 6% revenue growth during the fourth-quarter of 2025. Now that she has returned to the helm, Osteen has laid out a strategy to rebuild the company’s fortitude that includes tightening operations, reviewing leadership and ensuring projects are on track after it had to pause several de novo endeavors last fall.
Acadia is anticipating revenue for the first quarter of 2026 to land between $820 million and $830 million. Its full 2026 revenue estimates are expected to reach up to $3.45 billion.